Ascelia Pharma AB (publ)

BATS-CHIXE:ACES Stock Report

Market Cap: SEK 672.7m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Ascelia Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BATS-CHIXE:ACES Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Nov 24BuySEK 54,620Peter BensonIndividual20,000SEK 2.73
17 May 24BuySEK 102,516Carin LindeIndividual11,700SEK 8.82

Insider Trading Volume

Insider Buying: ACES insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ACES?
Owner TypeNumber of SharesOwnership Percentage
Private Companies459,8881.37%
Individual Insiders2,091,3646.21%
VC/PE Firms4,778,12914.2%
Institutions8,952,48626.6%
General Public17,386,39551.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 48.88% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
Sunstone Life Science Ventures A/S
4,778,129SEK 95.5m0%38.48%
6.56%
AP Fonden 4
2,209,266SEK 44.1m0%0.02%
4.01%
Handelsbanken Asset Management
1,350,823SEK 27.0m0%no data
3.56%
HealthInvest Partners AB
1,200,000SEK 24.0m0%3.77%
3.54%
Länsförsäkringar Fondförvaltning Aktiebolag
1,191,756SEK 23.8m0%0.01%
3%
Rene Spogard
1,010,203SEK 20.2m0%no data
2.82%
Ostvast Capital Management Limited
950,000SEK 19.0m0%25.46%
2.47%
Eiffel Investment Group S.A.S.
831,656SEK 16.6m0%2.21%
1.7%
Avanza Fonder AB
571,432SEK 11.4m0%0.03%
1.37%
Spogárd Holding Aps
459,888SEK 9.2m0%no data
1.04%
Bo Hansen
350,019SEK 7.0m0%no data
0.91%
Esaliens TFI S.A.
305,000SEK 6.1m0%0.26%
0.82%
Magnus Corfitzen
275,145SEK 5.5m8.91%no data
0.81%
Niels Mengel
271,267SEK 5.4m0%no data
0.74%
AP Fonden 2
250,000SEK 5.0m0%no data
0.5%
Xact Kapitalförvaltning AB
168,871SEK 3.4m0%no data
0.24%
SEB Investment Management AB
79,488SEK 1.6m0%no data
0.18%
Carl Bjartmar
61,400SEK 1.2m0%no data
0.12%
Julie Brogren
41,700SEK 833.2k56.2%no data
0.065%
Peter Benson
22,000SEK 439.5k46.7%no data
0.059%
Hans Maier
20,000SEK 399.6k0%no data
0.055%
Kristian Borbos
18,630SEK 372.2k0%no data
0.053%
Helena Wennerström
18,000SEK 359.6k0%no data
0.033%
Danske Bank A/S, Asset Management Arm
11,161SEK 223.0k0%no data
0.031%
Dimensional Fund Advisors LP
10,350SEK 206.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/08/31 17:01
End of Day Share Price 2022/06/03 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ascelia Pharma AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ludvig SvenssonCarnegie Commissioned Research
Lars HevrengDanske Bank
Ludvig SvenssonPenser Access